SEARCH RESULTS FOR:

Mining
DRC
MACIG

Adam Smits

EXECUTIVE DIRECTOR AND CHIEF OPERATING OFFICER, NZURI COPPER
MACIG 2019 Pre-Release
Nzuri Copper explains to GBR the strategy for its Kalongue copper and cobalt mine in the DRC.
Mining
Ghana
MACIG

Ghana: Breathing Life into a Maturing Sector

MACIG 2019 Pre-Release
Ghana’s mining industry has seen a great deal of success, but the competitiveness of the region’s leading gold producer may wane as juniors pursue less-explored terrain in countries with greater incentives to invest in greenfield projects.
Mining
Canada

Global Reach: Ontario Mining’s International Presence

Ontario Mining 2018 Pre-Release Edition
Home to the TSX and TSXV, both financial cornerstones of global mining, as well as a plethora of internationally focused mining companies, Ontario is a hub for global mining.
Mining
Canada

Pat Dubreuil &Richard Murphy

PRESIDENT & CEO, MANITOU GOLD
Ontario Mining 2018 Pre-Release Edition
Manitou Gold is exploring the Goudreau-Lochalsh Deformation Zone and discusses its plans with GBR.
Mining
Zambia
MACIG

Meshach Kwegyir-Aggrey

GENERAL MANAGER, CUMMINS ZAMBIA
MACIG 2019 Pre-Release
GBR speaks to Cummins in Zambia about its long presence in Southern Africa.
Mining
DRC
MACIG

Chetan Chug

MANAGING DIRECTOR, SOMIKA
MACIG 2018 PRE-RELEASE 2
GBR speaks to SOMIKA about its expanding operations in DRC.
Petrochemicals & Chemicals
Singapore

Singapore Chemicals 2018 IHS CW Release

Mining
Canada

Ontario Mining 2018 Pre-Release Edition

Mining
Cote d’Ivoire
Ghana
MACIG

Jeff Quartermaine

CEO & Managing Director, PERSEUS MINING
MACIG 2018 PRE-RELEASE 2
Perseus is an ASX and TSX-listed company based in Perth with a focus on West Africa.
Petrochemicals & Chemicals
India

India: Potential to Proceed

India Chemicals 2018 Pre-Release Edition
Expectation increases as development gathers pace.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL